Skip to content
Company Analysis

AngioDynamics, Inc. ANGO

A comprehensive view of key metrics, scores, and financial health for AngioDynamics, Inc.

Overview of AngioDynamics, Inc.

ANGO NMS
Healthcare Medical Instruments & Supplies Framework: Medical Devices & Diagnostics Small Cap
AngioDynamics, Inc. (ANGO), is a Small Cap company, in the Medical Instruments & Supplies industry, last closed at $11.76, about 14.3% overvalued vs fair value, +0.3% 1Y return, ranked 918/1145 in sector.
Metrics Rev Growth 9.5% ROE -20.8% Gross Margin 54.6%
USD 11.76
-1.92%
(Delayed)
• Vol 90d: 53.3%
52-Week Range
Market Cap
$494.56M
Enterprise Value
$464.71M
Overall Score
View breakdown
Overall
Growth
Weak
Profitability
Fair
Health
Weak
Efficiency
Fair
Valuation
Weak
Growth
Weak
Profitability
Fair
Health
Weak
Efficiency
Fair
Valuation
Weak
Completeness: 76%
Confidence: 87%
Updated: Oct 31
Top Beats

Quick Facts

Website https://www.angiodynamics.com
HQ Latham, NY
Employees 675
Fiscal year May 31

Next Events

Earnings Jan 6 Estimated

Fair Value Snapshot

Bear Base Bull
$9
$10
$12
Current: $11.76 -14% vs base

Engine Room Money Flow™

Small Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$320.2M
9.5%%
Gross Profit
$174.9M
10.9%%
Operating Income (GAAP)
-$39.9M
0.1%%
EBITDA
$626.0K
-64%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
54.6%
Good

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
5
Active Leaks
0/5
Improving
1
High Impact
3
Critical
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating AngioDynamics, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
53
/100
Moderate
Scores based on quantitative metrics and qualitative factors
Full moat analysis

Key strengths

  • Stable Gross Margin Profile Gross margin stability is strong (score 0.80). Low volatility confirms durable consumable pricing.
  • Improving FCF Trend FCF trend score is positive (score 0.65). Improving FCF margin signals compounding operational leverage.

Key risks

  • Weak Capital Return Profile Capital return quality is below peers (score 0.38). Low ROIC raises questions about M&A discipline and pipeline ROI.
  • Below-Peer Operating Margin Operating margin level is below peers (score 0.40). SG&A leverage needs improvement to close the gap.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Moderate
65
Premium

Signals, strengths and risks for Pricing Power & Consumable Moat

Premium

Signals, strengths and risks for R&D Pipeline & Capital Returns

Premium

Signals, strengths and risks for FCF Quality & Cash Conversion

Premium

Signals, strengths and risks for Commercial Execution

Premium

Signals, strengths and risks for Capital Structure & Resilience

Premium

Signals, strengths and risks for Growth Durability

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 92% Coverage
Trade-Off Triangle Visualization A ternary plot showing ANGO's balance between Growth (24.1%), Profitability (31.4%), and Safety (44.5%). Growth 24% Safety 45% Profitability 31%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

40th percentile vs peers
40
Key Signals
Rev Growth YoY 9.5% 57p Revenue CAGR 3Y -1.9% 27p EPS Growth YoY -6.3% 27p Asset Growth YoY -4.6% 36p
Strengths
  • Net Debt/EBITDA in top 20% of peers (-29.89, 97th percentile)
  • Debt/Assets in top 20% of peers (1.4%, 91th percentile)
  • Conservative leverage compared to industry peers
Risks
  • Growth below peer median (percentile: 40)

Profitability

52th percentile vs peers
52
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

74th percentile vs peers
74
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for AngioDynamics, Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$10.08
- - -
-14.3% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000